11:27 AM EST - Knight Therapeutics Inc. : Today reported financial results for its third quarter ended September 30, 2025. Revenues were $121,548, an increase of $29,285 or 32% over the same period in prior year. Net loss was $3,791, compared to a net income of $85 in the same period in prior year. Knight Therapeutics Inc.
shares T.GUD are trading up $0.24 at $6.08.
